Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 454.00M | £ 540.00M | £ 377.00M | £ 210.00M | £ 258.00M |
Total Assets | £ 7.88B | £ 7.21B | £ 7.02B | £ 6.67B | £ 6.88B |
Total Debt | £ 2.75B | £ 2.59B | £ 2.57B | £ 2.36B | £ 2.65B |
Net Debt | £ 2.29B | £ 2.05B | £ 2.20B | £ 2.15B | £ 2.39B |
Total Liabilities | £ 4.21B | £ 3.96B | £ 3.86B | £ 3.71B | £ 3.87B |
Stockholders Equity | £ 3.54B | £ 3.11B | £ 3.04B | £ 2.85B | £ 2.90B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |